Bryan, Garnier & Co's News

Adocia: New phase Ib start with BC lispro

BUY, Fair Value EUR113 (+52%)
News published on
September Wednesday 30, 2015


A new phase Ib study is starting with BC lispro in type II diabetes. Lilly, whose Diabetes franchise has strengthened a lot with Trulicity and Jardiance recently, shows strong commitment to BC lispro. It is still the prime asset of Adocia. We still expect a phase III start in H1 2016.


For more information, please contact marketing@bryangarnier.com